title: Epidemiological, clinical and therapeutic aspects in special situations: hidradenitis suppurativa in paediatric patients.
abstract: Hidradenitis suppurativa usually develops in the third decade of life and is infrequent in children and adolescents. This article reviews the scant epidemiological clinical and therapeutic data that are available for this age group. From the epidemiological point of view, reports have been more numerous in children, which has been related to hormone alterations and with a possibly higher genetic load than when this disease develops in adults. Clinically, it seems that when hidradenitis suppurativa develops in young patients, there is greater disease extension. The therapeutic approach is especially complex, since there is hardly any scientific evidence to serve as a basis for decisions. The challenges posed by this disease are to help patients accept their disease, recommend them healthy lifestyle habits and choose the most appropriate treatment for each patient.
authors.affiliation: Sección de Dermatología Pediátrica, Hospital Universitario La Paz, Madrid, España.
authors.forename: A
authors.initials: A
authors.lastname: Rodríguez Bandera
authors.affiliation: Sección de Dermatología Pediátrica, Hospital Universitario La Paz, Madrid, España. Electronic address: rauldelucas@gmail.com.
authors.forename: R
authors.initials: R
authors.lastname: de Lucas Laguna
mesh_terms: D000293:Adolescent; D017668:Age of Onset; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D015897:Comorbidity; D003863:Depression / Q000453:epidemiology; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D020022:Genetic Predisposition to Disease; D012739:Gonadal Steroid Hormones / Q000502:physiology; D006293:Health Promotion; D017497:Hidradenitis Suppurativa / Q000453:epidemiology / Q000235:genetics / Q000473:pathology / Q000628:therapy; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology; D009765:Obesity / Q000453:epidemiology; D010641:Phenotype; D015995:Prevalence; D012907:Smoking / Q000453:epidemiology
chemical_list: D000890:Anti-Infective Agents; D003879:Dermatologic Agents; D012739:Gonadal Steroid Hormones; D006728:Hormones; D007166:Immunosuppressive Agents
keywords: Adolescentes; Adolescents; Children; Hidradenitis suppurativa; Hidradenitis supurativa; Niños